Related content

Response to Letter to the Editor: Risk prediction models for chemotherapy-induced nausea and vomiting: almost ready for prime time?: Dranitsaris and Clemons

By Molassiotis Alex   Kontopantelis Evan  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 865-866

Springer Publishing Company

Access to resources Recommend Favorite

The cost of chemotherapy-induced nausea and vomiting in Italy

By Ballatori Enzo   Roila Fausto   Ruggeri Benedetta   Porrozzi Stella   Iannopollo Mauro   Soru Giancarla   Cruciani Giorgio   Daniele Bruno   Locatelli Maria   Pellissier James   Deuson Robert  

Supportive Care in Cancer, Vol. 15, Iss. 1, 2007-01 ,pp. : 31-38

Springer Publishing Company

Access to resources Recommend Favorite

New treatment options for chemotherapy-induced nausea and vomiting

By Hesketh Paul  

Supportive Care in Cancer, Vol. 12, Iss. 8, 2004-08 ,pp. : 550-554

Springer Publishing Company

Access to resources Recommend Favorite

Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review

By Hocking Christopher   Kichenadasse Ganessan  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 1143-1151

Springer Publishing Company

Access to resources Recommend Favorite

Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity

By Vig Sierra   Seibert Laurel   Green Myke  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 1, 2014-01 ,pp. : 77-82

Springer Publishing Company

Access to resources Recommend Favorite